{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:05:15Z","timestamp":1790643915223,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022313","name":"Union Nationale des Aveugles et D\u00e9ficients Visuels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013875","name":"Retina France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-IAHU-0001"],"award-info":[{"award-number":["ANR-18-IAHU-0001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019125","name":"Sorbonne Universit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109332","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T05:53:12Z","timestamp":1668145992000},"page":"109332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["P2X7-dependent immune pathways in retinal diseases"],"prefix":"10.1016","volume":"223","author":[{"given":"Paul-Alexandre","family":"D\u00e9chelle-Marquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Guillonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Sennlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9739-4306","authenticated-orcid":false,"given":"C\u00e9cile","family":"Delarasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109332_bib1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases in vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2022.109332_bib2","doi-asserted-by":"crossref","first-page":"33206","DOI":"10.1074\/jbc.274.47.33206","article-title":"Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor","volume":"274","author":"Baricordi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109332_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/db10-0104","article-title":"Interleukin-1beta produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: implications for the timing of tolerizing immunotherapy","volume":"60","author":"Bertin-Maghit","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2022.109332_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","article-title":"Purinergic nerves","volume":"24","author":"Burnstock","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109332_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0306-4522(76)90054-3","article-title":"Do some nerve cells release more than one transmitter?","volume":"1","author":"Burnstock","year":"1976","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109332_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109332_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0306-3623(85)90001-1","article-title":"Is there a basis for distinguishing two types of P2-purinoceptor?","volume":"16","author":"Burnstock","year":"1985","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.1972.tb06868.x","article-title":"A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species","volume":"46","author":"Burnstock","year":"1972","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102139","article-title":"P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy","volume":"206","author":"Carvalho","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib10","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109332_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/eji.201343353","article-title":"The purinergic P2x7 receptor is expressed on monocytes in Behcet's disease and is modulated by TNF-alpha","volume":"44","author":"Castrichini","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib12","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.4049\/jimmunol.176.5.3115","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-\/- mice: evidence for loss of apoptotic activity in lymphocytes","volume":"176","author":"Chen","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib13","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI31692","article-title":"CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration","volume":"117","author":"Combadiere","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109332_bib14","doi-asserted-by":"crossref","first-page":"34583","DOI":"10.1074\/jbc.M112.400010","article-title":"Ezrin\/radixin\/moesin are required for the purinergic P2X7 receptor (P2X7R)-dependent processing of the amyloid precursor protein","volume":"287","author":"Darmellah","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109332_bib15","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","article-title":"The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein","volume":"286","author":"Delarasse","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109332_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2009.06008.x","article-title":"Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor","volume":"109","author":"Delarasse","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109332_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","article-title":"Liaisons dangereuses: P2X(7) and the inflammasome","volume":"28","author":"Di Virgilio","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/onc.2016.206","article-title":"Extracellular purines, purinergic receptors and tumor growth","volume":"36","author":"Di Virgilio","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2022.109332_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.cdd.4400341","article-title":"Cytolytic P2X purinoceptors","volume":"5","author":"Di Virgilio","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2022.109332_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2022.109332_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16490","article-title":"Subretinal mononuclear phagocytes induce cone segment loss via IL-1beta","volume":"5","author":"Eandi","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109332_bib22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.159.3.1451","article-title":"Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages","volume":"159","author":"Ferrari","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.185.3.579","article-title":"Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin","volume":"185","author":"Ferrari","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2022.109332_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(99)00270-7","article-title":"P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death","volume":"447","author":"Ferrari","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2022.109332_bib25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.drudis.2019.03.029","article-title":"Targeting P2X7 receptors as a means for treating retinal disease","volume":"24","author":"Fletcher","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2022.109332_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","article-title":"Danger signals: SOS to the immune system","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood.V92.3.946","article-title":"Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases","volume":"92","author":"Gu","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2022.109332_bib28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1096\/fj.12-215368","article-title":"A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration","volume":"27","author":"Gu","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.109332_bib29","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1101178","article-title":"P2X(7) is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP","volume":"187","author":"Gu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib30","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1111\/bph.14470","article-title":"P2X7 as a scavenger receptor for innate phagocytosis in the brain","volume":"175","author":"Gu","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.preteyeres.2017.06.002","article-title":"On phagocytes and macular degeneration","volume":"61","author":"Guillonneau","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.neuropharm.2022.109332_bib54","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.1001298","article-title":"Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes","volume":"185","author":"Hill","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib32","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1523\/JNEUROSCI.3955-14.2015","article-title":"Upregulation of P2RX7 in cx3cr1-deficient mononuclear phagocytes leads to increased interleukin-1beta secretion and photoreceptor neurodegeneration","volume":"35","author":"Hu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12974-018-1353-8","article-title":"A central role for P2X7 receptors in human microglia","volume":"15","author":"Janks","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.109332_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109332_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fncel.2019.00401","article-title":"Pleiotropic roles of P2X7 in the central nervous system","volume":"13","author":"Kanellopoulos","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib36","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1167\/iovs.13-12500","article-title":"TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy","volume":"54","author":"Kerur","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer's disease mouse model","volume":"24","author":"Martin","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109332_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/acel.12522","article-title":"Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology","volume":"16","author":"Martin","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2022.109332_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cell.2019.09.017","article-title":"Full-length P2X7 structures reveal how palmitoylation prevents channel desensitization","volume":"179","author":"McCarthy","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109332_bib40","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1167\/iovs.15-17440","article-title":"Nucleoside reverse transcriptase inhibitors suppress laser-induced choroidal neovascularization in mice","volume":"56","author":"Mizutani","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15252\/embj.201694615","article-title":"IL-1 signaling is critical for expansion but not generation of autoreactive GM-CSF+ Th17 cells","volume":"36","author":"Mufazalov","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2022.109332_bib42","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1523\/JNEUROSCI.21-18-07135.2001","article-title":"P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase","volume":"21","author":"Panenka","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.146","article-title":"Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: breaking the vicious cycle between IL-1beta and GM-CSF","volume":"62","author":"Pare","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109332_bib44","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2022.109332_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.112.3.297","article-title":"Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release","volume":"112","author":"Solini","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.3792-03.2004","article-title":"Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia","volume":"24","author":"Suzuki","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10384-018-0587-4","article-title":"Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis","volume":"62","author":"Takeda","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","article-title":"DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88","volume":"149","author":"Tarallo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2022.109332_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137110","article-title":"The P2X7 receptor: a promising pharmacological target in diabetic retinopathy","volume":"22","author":"Tassetto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109332_bib50","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.ajpath.2017.04.016","article-title":"Loss of function of P2X7 receptor scavenger activity in aging mice: a novel model for investigating the early pathogenesis of age-related macular degeneration","volume":"187","author":"Vessey","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2022.109332_bib51","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2022.109332_bib52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.immuni.2015.10.009","article-title":"Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2022.109332_bib53","article-title":"Blockade of extracellular ATP effect by oxidized ATP effectively mitigated induced mouse experimental autoimmune uveitis (EAU)","volume":"11","author":"Zhao","year":"2016","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:10Z","timestamp":1758439270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822003914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":54,"alternative-id":["S0028390822003914"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109332","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2X7-dependent immune pathways in retinal diseases","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109332"}}